| 1 |
23652277 | A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy. | 2013 Aug |
1 |
| 2 |
21352196 | Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals. | 2011 Apr |
1 |
| 3 |
20634492 | Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance. | 2010 Nov |
1 |